Article info
PDFShort report
Levels of CSF prostaglandin E2, cognitive decline, and survival in Alzheimer’s disease
- Correspondence to: Dr Luisa Minghetti Department of Cell Biology and Neurosciences, Section of Degenerative and Inflammatory Neurological Diseases, Istituto Superiore di Sanità, Viale Regina Elena, 299, 00161 Rome, Italy; luisa.minghetti{at}iss.it
Citation
Levels of CSF prostaglandin E2, cognitive decline, and survival in Alzheimer’s disease
Publication history
- Received January 11, 2005
- Accepted May 18, 2005
- Revised May 3, 2005
- First published June 8, 2005.
Online issue publication
April 13, 2016
Article Versions
- You are viewing the most recent version of this article.
- Previous version (13 April 2016).
- latest version (21 October 2016).
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2006 Journal of Neurology Neurosurgery and Psychiatry